MJA
MJA

Salicylate intoxication from teething gel in infancy

Med J Aust 2011; 194 (3): 146-148.

Clinical records

Please login with your free MJA account to view this article in full

  • Gary D Williams1
  • Edwin P Kirk1
  • Callum J Wilson2
  • Caroline A Meadows3
  • Betty S Chan4

  • 1 Sydney Children’s Hospital, Sydney, NSW.
  • 2 Starship Hospital, Auckland, New Zealand.
  • 3 Whangarei Hospital, Whangarei, New Zealand.
  • 4 Prince of Wales Hospital, Sydney, NSW.

Correspondence: g.williams@unsw.edu.au

Acknowledgements: 

We would like to acknowledge the parents of our two patients for giving permission for the case histories to be presented.

Competing interests:

None identified.

  • 1. McIntire MS, Angle CR. Aspirin fatalities — the new taxonomy. Pediatrics 1982; 69: 249-252.
  • 2. Flomenbaum NE. Salicylates. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, et al, editors. Goldfrank’s toxicological emergencies. New York: McGraw-Hill, 2006: 550-562.
  • 3. Levy G. Clinical pharmacokinetics of aspirin. Pediatrics 1978; 62 (5 Suppl): 867-872.
  • 4. Pearlman BL, Gambhir R. Salicylate intoxication: a clinical review. Postgrad Med 2009; 121: 162-168.
  • 5. Haddad LM, Shannon MW, Winchester JF. Clinical management of poisoning and drug overdose. 3rd ed. Philadelphia: WB Saunders Company, 1998.
  • 6. Segar WE, Holliday MA. Physiologic abnormalities of salicylate intoxication. N Engl J Med 1958; 259: 1191-1194.
  • 7. Glasgow AM, Chase HP. Effect of salicylate on ureagenesis in rat liver. Proc Soc Exp Biol Med 1977; 155: 48-50.
  • 8. Gaudreault P, Temple AR, Lovejoy FH. The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 1982; 70: 566-569.
  • 9. Markman L. Teething: facts and fiction. Pediatr Rev 2009; 30: e59-64.
  • 10. Oman TK, Stewart MC, Burns A, Lang TF. Topical choline salicylates implicated in Reye’s syndrome. BMJ 2008; 336: 1376.
  • 11. Paynter AS, Alexander FW. Salicylate intoxication caused by teething ointment. Lancet 1979; 2: 1132.
  • 12. Sarll DW, Duxbury AJ. Choline salicylates and Reye’s syndrome. Br Dent J 1986; 161: 317-318.
  • 13. Committee on Safety of Medicines; Medicines Control Agency. Aspirin and Reye’s syndrome in children up to and including 15 years of age. Curr Prob Pharmacovigilance 2002; 28: 4. http://www.mhra.gov.uk/Publications/Safetyguidance/CurrentProblemsinPharmacovigilance/CON007453 (accessed Jan 2011).
  • 14. Medicines and Healthcare Products Regulatory Agency. New advice on oral salicylate gels in under 16s [press release]. 23 Apr 2009. http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON044014 (accessed Jan 2011).
  • 15. Medsafe. Update on the use of “teething” gels containing choline salicylate in children — results of Medsafe’s review. 7 May 2009. http://www.medsafe.govt.nz/hot/media/2009/teething.asp (accessed Dec 2010).
  • 16. James S. Review of aspirin/Reye’s syndrome warning statement. Medicines Evaluation Committee, April 2004. http://www.tga.gov.au/npmeds/aspirin_reye.pdf (accessed Dec 2010).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article